Skip to content
AtessiaAtessia Life Science Advisors
  • Home
  • Expertise
  • Services
    • Medicines
      • Exploitant – Pharmaceutical establishment
        • Find / Open a French “Exploitant” pharmaceutical company
        • Activities related to quality
        • External communications
        • Relation betwenn healthcare professionals & Compliance
        • Pharmacovigilance
      • Regulatory & Pharmaceutical Strategy
      • Research & Development Consulting
      • Marketing authorisation
        • Registration: Drafting & Submitting MA files
        • Post-MA lifecycle management
    • Medical devices
    • Consulting subscription
    • Audits
    • Regulatory monitoring
    • Training
    • Atessia Vigilances
  • Strengths
  • News
    • Company
    • Events
  • Blog
  • Join Atessia
  • Contact
  • English
    • Français
    • English

Our latest News & Events

Company

Welcome to Hiba MASSOUDY

Read more »
June 7, 2021
Company

Welcome to Stéphanie DURLIN

Read more »
June 1, 2021
Company

Welcome to Amarylys! ✨

Read more »
May 25, 2021
Company

AFAR: Reform of the ATU/RTU access measures

Read more »
May 20, 2021
Company

FEFIS: Atessia in the 2020 membership register.

Read more »
March 17, 2021
Event

Atessia Event – Early and Compassionate Access Reform

Read more »
March 3, 2021
Company

Atessia is 4 years old!!

Read more »
February 10, 2021
Company

Welcome to Raphaël Dauvergne

Read more »
October 6, 2020
Event

Atessia Event – Webinar New “Anti-Gift” Regulations

Read more »
September 11, 2020
Page1 Page2 Page3 Page4

ATESSIA, Life Science Advisors
3, Rue d’Uzès – 75002 PARIS
hello@atessia.fr
+33 1.70.22.66.19

Atessia Life Science Advisors

Follow-us

Legal notices

Terms and Conditions of Sale

ATESSIA SAS with capital of €5,000.00 I RCS PARIS 827 777 319

Copyright © 2021 | Powered by Atessia